Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid vs nitroglycerin vs remifentanil for bleeding prevention during lumbar disc surgery
IRCT20141209020258N159Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Herniated Lumbar Disk comparing Remifentanil arm, Tranexamic acid arm and Nitroglycerin arm (3 arms). Primary endpoints: Bleeding and Surgeon consent. Started Jun 2021; status: completed.
02
Drugs
tranexamic acidnitroglycerinremifentanil
03
Conditions
Herniated Lumbar Disk
Beyond the preview
Go deeper on IRCT20141209020258N159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N159.